» Articles » PMID: 39177882

Performance Evaluation of a Combination Plasmodium Dual-antigen CRP Rapid Diagnostic Test in Lambaréné, Gabon

Abstract

Purpose: The consequent use of malaria rapid diagnostic tests (RDTs) preceding a treatment decision has improved the global management of malaria. A combination RDT, including an inflammation marker to potentially guide antibiotic prescription, could improve the management of acute febrile illness (AFI).

Methods: We performed a prospective, cross-sectional study in Gabon evaluating the STANDARD Malaria/CRP DUO (S-DUO) RDT. Participants aged 2 to 17 years with fever at presentation and/or a history of fever < 7 days were enrolled. Expert microscopy, SD Bioline Malaria Ag P.f/Pan test for malaria detection, and NycoCard CRP device for CRP were used as comparators. AFI cases were classified on a spectrum encompassing bacterial vs. non-bacterial infection.

Results: 415 participants with AFI were enrolled. S-DUO RDT sensitivity and specificity for malaria detection vs. microscopy were 99·1% (95·2-100%) and 72·7% (64·3-80·1%); and for CRP detection (20 mg/L and above) 86·9% (80-92%) and 87% (79·2-92·7%), respectively. The difference in CRP levels between bacterial infection (mean = 41·2 mg/L) and other causes of fever, measured from our study population using the Nycocard device, was statistically significant (p < 0·01); CRP precision-recall AUC to distinguish bacterial infection class vs. non-bacterial classifications was 0·79.

Conclusion: S-DUO RDT is suitable for malaria detection in moderate-to-high malaria transmission settings such as in Lambaréné; however, a CRP band detection limit > 40 mg/L is more adequate for indication of antibiotic prescription for AFI cases in Gabon.

Citing Articles

Epidemiology and diversity of Plasmodium species in Franceville and their implications for malaria control.

Boundenga L, Sima-Biyang Y, Longo-Pendy N, Bignoumba M, Mbou-Boutambe C, Moukagni-Mussadji C Sci Rep. 2024; 14(1):31977.

PMID: 39738526 PMC: 11686293. DOI: 10.1038/s41598-024-83487-0.

References
1.
Escadafal C, Geis S, Siqueira A, Agnandji S, Shimelis T, Tadesse B . Bacterial versus non-bacterial infections: a methodology to support use-case-driven product development of diagnostics. BMJ Glob Health. 2020; 5(10). PMC: 7580043. DOI: 10.1136/bmjgh-2020-003141. View

2.
Diez-Padrisa N, Bassat Q, Machevo S, Quinto L, Morais L, Nhampossa T . Procalcitonin and C-reactive protein for invasive bacterial pneumonia diagnosis among children in Mozambique, a malaria-endemic area. PLoS One. 2010; 5(10):e13226. PMC: 2954814. DOI: 10.1371/journal.pone.0013226. View

3.
Gillet P, Mori M, Van Esbroeck M, van den Ende J, Jacobs J . Assessment of the prozone effect in malaria rapid diagnostic tests. Malar J. 2009; 8:271. PMC: 2789093. DOI: 10.1186/1475-2875-8-271. View

4.
Althaus T, Greer R, Swe M, Cohen J, Tun N, Heaton J . Effect of point-of-care C-reactive protein testing on antibiotic prescription in febrile patients attending primary care in Thailand and Myanmar: an open-label, randomised, controlled trial. Lancet Glob Health. 2018; 7(1):e119-e131. PMC: 6293968. DOI: 10.1016/S2214-109X(18)30444-3. View

5.
Bonko M, Karama I, Kiemde F, Lompo P, Garba Z, Yougbare S . Could combined rapid diagnostic testing for malaria and c-reactive protein be helpful for the diagnosis and management of febrile illnesses in children under-5 years of age in rural Burkina Faso?. BMC Infect Dis. 2022; 22(1):952. PMC: 9764475. DOI: 10.1186/s12879-022-07638-2. View